Table 2.

Characteristics of patients with NCDs served by targeted PHC clinics, n=569

Characteristics	Male (n=206/36%)	Female (n=363/64%)	Total (n=569)
Age (µ±SD)	53.5±15.2	49.75±14.2	51.8±14.2
Patients with NCD who attended facilities
Hypertension	155 (75.2%)	277 (76.3%)	432 (75.9%)
Diabetes	23 (11.2%)	47 (13.0%)	70 (12.3%)
Asthma/COPD	10 (4.9%)	17 (4.7%)	27 (4.7%)
Depression	1 (0.5%)	8 (2.2%)	9 (1.6%)
Sickle cell anaemia	6 (3.0%)	1 (0.3%)	7 (1.2%)
Epilepsy	3 (1.5%)	3 (0.8%)	6 (1.1%)
Other NCDs	8 (3.9%)	10 (2.8%)	18 (3.2%)
Total	206 (100%)	363 (100%)	569 (100%)
New diagnosis of NCDs
Yes	145 (70.4%)	269 (74.2%)	414 (72.7%)
No	61 (29.6%)	94 (25.8%)	155 (27.3%)
Total	206 (100%)	363 (100%)	569 (100%)
Check-up items
Height (µ±SD)	1.56±0.14	1.56±0.11	1.56±0.12
Weight (µ±SD)	67.4±12.6	68.5±12.4	68.1±12.5
BMI
Normal 18.5–24	57 (27.7%)	114 (31.4%)	171 (30.0%)
Overweight 25–30	78 (37.9%)	124 (34.1%)	202 (35.5%)
Obese ≥30	62 (30.1%)	122 (33.6%)	184 (32.3%)
Total	206 (100%)	363 (100%)	569 (100%)
BP
Normal BP 90/60–120/80 mm Hg	52 (25.2%)	73 (20.1%)	125 (22.7%)
High normal 130/85−139/89 mm Hg	21 (10.2%)	38 (10.5%)	59 (10.4%)
High BP ≥140/90 mm Hg	133 (64.6%)	252 (69.4%)	385 (67.7)
Total	206 (100%)	363 (100%)	569 (100%)
Diagnostic tests
FBS
Normal reading <5.6 mmol/L	30 (40.0%)	56 (40.0%)	86 (40.0%)
Pre-diabetes 5.6–6.9 mmol/L	15 (20.0%)	32 (23%)	47 (21.9%)
Diabetes reading >7.0 mmol/L	30 (40.0%)	52 (37.1%)	82 (38.1%)
Total	75 (100%)	140 (100%)	215 (100%)
Urine analysis
Normal	32 (69.6%)	57 (65.5%)	89 (66.9%)
Proteinuria and/or glycosuria*	14 (30.4%)	30 (34.5%)	44 (33.1%)
Total recorded	46 (100%)	87 (100%)	133 (100%)

*Proteinuria—proteins in urine, glycosuria—sugar in urine. According to the NCD guideline, fasting blood glucose taken if overweight or have related symptoms, and urine analysis as indicated.

BP, blood pressure; COPD, chronic obstructive pulmonary disease; FBS, fasting blood sugar; NCD, non-communicable disease.